NO995040L - 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander - Google Patents

5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander

Info

Publication number
NO995040L
NO995040L NO995040A NO995040A NO995040L NO 995040 L NO995040 L NO 995040L NO 995040 A NO995040 A NO 995040A NO 995040 A NO995040 A NO 995040A NO 995040 L NO995040 L NO 995040L
Authority
NO
Norway
Prior art keywords
oxadiazol
azabicyclo
oct
aryl
derivatives
Prior art date
Application number
NO995040A
Other languages
English (en)
Norwegian (no)
Other versions
NO995040D0 (no
Inventor
Samir Jegham
Alistair Lochead
Frederic Galli
Alain Nedelec
Axelle Samson
Thierry Gallet
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995040D0 publication Critical patent/NO995040D0/no
Publication of NO995040L publication Critical patent/NO995040L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO995040A 1997-04-18 1999-10-15 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander NO995040L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704802A FR2762316B1 (fr) 1997-04-18 1997-04-18 Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
PCT/FR1998/000754 WO1998047898A1 (fr) 1997-04-18 1998-04-15 Derives de 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one en tant que ligands des recepteurs 5-ht4

Publications (2)

Publication Number Publication Date
NO995040D0 NO995040D0 (no) 1999-10-15
NO995040L true NO995040L (no) 1999-12-16

Family

ID=9506076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995040A NO995040L (no) 1997-04-18 1999-10-15 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander

Country Status (32)

Country Link
US (1) US6255319B1 (de)
EP (1) EP0975631B1 (de)
JP (1) JP2001521542A (de)
KR (1) KR20010006452A (de)
CN (1) CN1260794A (de)
AR (1) AR012458A1 (de)
AT (1) ATE206424T1 (de)
AU (1) AU742666B2 (de)
BG (1) BG64053B1 (de)
BR (1) BR9808926A (de)
CA (1) CA2286106A1 (de)
CO (1) CO4750656A1 (de)
CZ (1) CZ289154B6 (de)
DE (1) DE69801905T2 (de)
DK (1) DK0975631T3 (de)
EE (1) EE03769B1 (de)
ES (1) ES2165162T3 (de)
FR (1) FR2762316B1 (de)
HU (1) HUP0002456A3 (de)
IL (1) IL132352A0 (de)
NO (1) NO995040L (de)
NZ (1) NZ500396A (de)
PL (1) PL186894B1 (de)
PT (1) PT975631E (de)
RU (1) RU2186066C2 (de)
SI (1) SI0975631T1 (de)
SK (1) SK283441B6 (de)
TR (1) TR199902600T2 (de)
TW (1) TW502005B (de)
UA (1) UA57071C2 (de)
WO (1) WO1998047898A1 (de)
ZA (1) ZA983257B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
CN1764458A (zh) * 2003-03-26 2006-04-26 麦克公司 作为黑皮质素－4受体激动剂的双环哌啶衍生物
US7321042B2 (en) * 2003-10-16 2008-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for preparing N-substituted 3-β-aminonortropanes
AU2004290520A1 (en) * 2003-11-18 2005-06-02 Boehringer Ingelheim International Gmbh Solid pharmaceutical preparation form
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
CA2569654C (en) 2004-06-15 2010-12-21 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
FR2873693B1 (fr) * 2004-07-29 2006-09-15 Sanofi Synthelabo Derives d'amino-tropane, leur preparation et leur application en therapeutique
ATE469897T1 (de) * 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen
SE532388C2 (sv) * 2008-03-14 2010-01-12 Tetra Laval Holdings & Finance Förpackningslaminat och -behållare med två separata gasbarriärskikt samt metod för deras framställning
US9051309B2 (en) 2013-03-15 2015-06-09 Monsanto Technology Llc 3,5-disubstituted-1,3,4-oxadiazol-2(3H)-ones and compositions and methods for controlling nematode pests
GB201814151D0 (en) * 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055476A (en) * 1990-08-13 1991-10-08 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
SG49153A1 (en) * 1991-09-12 1998-05-18 Smithkline Beecham Plc 5-HT4 receptor antagonists
EP0554794B1 (de) * 1992-02-04 1998-07-29 Eisai Co., Ltd. Aminobenzoesäure Derivate
EP0625149A1 (de) * 1992-02-06 1994-11-23 Smithkline Beecham Plc Benzopyran-, Benzothiopyran- und Benzofuran-Derivate als 5-HT4-Antagonisten
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
ES2135934T3 (es) * 1995-11-09 1999-11-01 Sanofi Synthelabo Compuesto eventualmente bajo la forma de isomero optico puro o de mezcla de tales isomeros.

Also Published As

Publication number Publication date
AU742666B2 (en) 2002-01-10
DE69801905D1 (de) 2001-11-08
JP2001521542A (ja) 2001-11-06
ZA983257B (en) 1998-10-19
KR20010006452A (ko) 2001-01-26
FR2762316A1 (fr) 1998-10-23
TR199902600T2 (xx) 2000-03-21
BG103810A (en) 2000-06-30
FR2762316B1 (fr) 1999-12-17
NO995040D0 (no) 1999-10-15
EE9900487A (et) 2000-06-15
BR9808926A (pt) 2000-08-01
EP0975631A1 (de) 2000-02-02
HUP0002456A3 (en) 2001-03-28
ES2165162T3 (es) 2002-03-01
IL132352A0 (en) 2001-03-19
ATE206424T1 (de) 2001-10-15
EE03769B1 (et) 2002-06-17
CN1260794A (zh) 2000-07-19
CO4750656A1 (es) 1999-03-31
PT975631E (pt) 2002-03-28
SK283441B6 (sk) 2003-07-01
TW502005B (en) 2002-09-11
BG64053B1 (bg) 2003-11-28
SI0975631T1 (en) 2002-06-30
WO1998047898A1 (fr) 1998-10-29
UA57071C2 (uk) 2003-06-16
NZ500396A (en) 2001-04-27
PL186894B1 (pl) 2004-03-31
SK142699A3 (en) 2000-05-16
RU2186066C2 (ru) 2002-07-27
HUP0002456A2 (hu) 2000-12-28
CA2286106A1 (en) 1998-10-29
AR012458A1 (es) 2000-10-18
DE69801905T2 (de) 2002-07-04
CZ289154B6 (cs) 2001-11-14
CZ364199A3 (cs) 2000-03-15
DK0975631T3 (da) 2002-01-28
PL336315A1 (en) 2000-06-19
AU7341598A (en) 1998-11-13
EP0975631B1 (de) 2001-10-04
US6255319B1 (en) 2001-07-03

Similar Documents

Publication Publication Date Title
NO982092D0 (no) 5-fenyl-3-(piperidin-4-yl)-1,3,4-oksadiazol-2(3H)-on-derivater for anvendelse som 5-HT4 eller H3 reseptorligander
MA26542A1 (fr) Derives oxindole substitues.
FI884350A7 (fi) Som antagonister nyttiga nya benzimidazolin-2-oxo-1-karboxylsyraderivat av 5-ht reseptor.
SG71077A1 (en) 8-Substituted-1,3, 8-triaza-spiro (4.5)decan-4-on derivatives
NO913786L (no) Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.
NO980273D0 (no) Femleddede heterocykluser med bifenylsulfonylsubstitusjon fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
ZA9811473B (en) Arylpiperazines having activity at the serotonin 1A receptor.
NO995040L (no) 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander
DK0921125T3 (da) 1,3,8-triazaspiro[4.5]decan-4-on-derivater
NO20002036D0 (no) Cyklopentenderivater nyttig som antagonister for motilinreseptoren
TR199901381A3 (tr) Diaza-spiro[3,5]nonan türevleri.
FI894276L (fi) Gaongjaern foer wc-sits.
NO994106D0 (no) Oksazolidiner som 5-HT2A-antagonister
AU2095099A (en) Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists
FI922903A0 (fi) 4-acetoxipiperidin derivat, deras framstaellningsfoerfarande och anvaendning som antagonist foer muskarina m-3 receptorer.
FR2702163B1 (fr) Tour automatique multibroches.
FI943872A0 (fi) 2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina
NO894707D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
DK1133494T3 (da) 8-Azabicyclo[3.2.1]oct-2-en-derivater
NO952426D0 (no) Nytt legemiddel som inneholder 3,7-diazabisyklo[3,3,1Ånonan forbindelser
AU2178299A (en) 8-azabicyclo(3.2.1)oct-2-ene derivatives as pesticides
FI904279A0 (fi) Pyrido-(3,2,1-ij)-1,3,4 -benzoxadiazin-6-karboxylsyraderivat.
AU7658898A (en) 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4ligands
ZA974684B (en) Benzoxazinone dopamine D4 receptor antagonists.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application